Antirotavirus immunogobulin Y (Newsummit Biopharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAntirotavirus immunogobulin Y (Newsummit Biopharma)
Drug Alias Nameantirotavirus IgY (infant diarrhea)抗轮状病毒免疫球蛋白Y-上海新生源医药
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDiarrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Xinshengyuan Biological Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Xinshengyuan Biological Medicine Co Ltd
Active IndicationsN/A
Inactive IndicationsDiarrhea

Other Information

ATC CodeN/A
Related LinksN/A